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ABSTRACT
Premature rupture of membrane (PROM) is produced when amniotic membranes tear before labor onset and is recorded in around 8 % of full-term 
gestations. Preterm PROMs (PPROMs) take place before the 37th week of gestation, with an incidence of 2–4 % of pregnancies, and it is associated 
with higher maternal and perinatal morbidity and mortality, mainly related to infectious processes and prematurity. Among maternal complications, 
which include postpartum infection, premature placental detachment, and maternal sepsis, we highlight clinical chorioamnionitis for its incidence 
and severity. Of decreasing frequency, perinatal complications include respiratory distress, neonatal sepsis, intraventricular hemorrhage, necrotizing 
enterocolitis, and neurological lesions. Full-term PROM frequently has a physiological cause and is a consequence of uterine contractions; however, 
PPROM usually has a multifactorial etiology that is often unknown, although the most frequently reported cause is an infection, observed in up to 60 % 
of cases. Therefore, the etiology of PPROM, although probably infectious, remains unknown in most cases. The obstetric approach varies as a function 
of gestational age, actively inducing the pregnancy in full-term PROM but performing an overall evaluation of maternal-fetal status in PPROM. In the 
latter situation, an assessment is made of the relative risks and benefits of a wait-and-see attitude versus pregnancy induction, considering signs of 
infection and/or prematurity, and ordering antibiotic treatment when PPROM is diagnosed . Multiple combinations of antimicrobial drugs have been 
proposed and better perinatal and maternal outcomes have been reported for the prophylactic administration of some new combinations. This study 
describes a case of PPROM caused by urinary tract infection.
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INTRODUCTION
Preterm premature rupture of membranes (PPROM) before the 37th week 
of gestation usually has a multifactorial etiology that is often unknown 
[1-4]. Although the most frequently reported cause is infection by group 
B Streptococcus with incidence 4-8% [1-4]. PPROM is the commonest 
precursor of preterm birth, and can lead to death, neonatal disease, 
and long-term disability [5-8]. The previous studies showed that, small 
trials of antibiotics for PPROM suggested some health benefits for the 
neonate, but the results were unsatisfying [5-8]. Moreover, maternal 
genitourinary infection during pregnancy might be prevented with 
appropriate screening and treatment programs before and during early 
pregnancy that need to be supported by ministry of health agenda [7-8]. 
This case describes a PPROM caused by urinary tract infection.
CASE REPORT
We report the case of a 32-year-old pregnant woman from khan Younis 
in her 32nd gestational week with a history of two previous full-term 
eutocic deliveries, and one C/S delivery due to antepartum hemorrhage 
(placenta previa).
The reported case arrived at the emergency obstetrics and gynecology 
department due to the vaginal discharge of clear fluid, with no uterine 
contractions or bleeding. According to the case clinical records, she had 
no previous an ultrasonography examination during her pregnancy 
period. The gestational age was estimated as 32  weeks+5 days by 
ultrasonic fetal biometry. Mother during her first admission showed 
conscious and oriented X3. The routine V/S was within normal range, 
recorded blood pressure was 100/80 mmHg taken from the left arm at 
supine position, temperature 37c axillary, respiratory rate was 19 b/m 
with shallow regular, pulse 75 bpm, and intravenous (IV) cannula was 
fixed at right. There was no sign of inflammation on the IV site. The 
mother was C/O mild abdominal pain, low back pain, mother advised 
to stay at complete bed rest. Examination with a sterile speculum in the 
emergency department revealed the release of clear amniotic fluid, while 
tran-svaginal ultrasound showed a closed cervix, abdominal ultrasound 
showed that a normal amount of amniotic fluid and biometrics indicated 
32+0 weeks of gestation. Urine, endocervical, and vaginal-rectal cultures 
were taken, and complete blood and urine analyses were performed. 
The cardiotocographic record at admission showed good fetal reactivity 
and the absence of uterine contractions in that time.
Post-admission, the hospital protocol for preterm premature rupture of 
membrane (PPROM), was followed, administering antibiotic therapy with 
erythromycin (250 mg orally) and corticosteroids as dexamethasone 
(4 mg IM) for lung maturation, tocolytic medication as MgSo4 (4 g/100 
ml Nacl/20 min loading dose) these used to stop preterm labor. Although 
the mother remained clinically stable and afebrile, the labor was induced 
with IV oxytocin followed by eutocic delivery in gestation week 33+4 
after the patient signed her informed consent.
The motive for the induction was suspicion of subclinical 
chorioamnionitis, based on her increasing leukocytosis, neutrophilia, 
and C-reactive protein (CRP) levels since admission (leukocytosis of 
11 030 at admission vs. 14 650 at induction, neutrophilia of 83 % at 
admission: vs. 81 % at induction, and CRP of 11.27 mg l−1 at admission 
vs. 37 mg l−1 at induction). The cardiotocography remained normal, 
with no uterine tenderness. The newborn was female and weighed 
1970 g, with Apgar scores at 1 and 5 min of 9 and 10, respectively, and 
she was admitted to the neonatal intensive care unit (NICU). During 
her NICU stay, the newborn remained clinically stable, with no need for 
vasoactive drugs or other advanced support measures, and she received 
prophylactic antibiotherapy in accordance with the hospital protocol. 
Cultures were taken at admission and throughout the NICU stay were 
negative for infections, the newborn was discharged at 13 days of life 
with a weight of 2180 g, cephalic perimeter of 32 cm and length of 
47 cm, and no abnormal clinical findings.
Case Report
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DISCUSSION
PPROM of infectious etiology is an entity with potentially severe 
maternal-fetal morbidity and mortality and an added risk of 
prematurity. In the majority of cases, the pathogen derives from urinary 
tract infection, our experience of epidemiologic changes in the etiology 
of PPROM means that a more complete diagnostic procedure must be 
followed, with wider analytic studies, adapting available diagnostic 
procedures to clinical needs. New culture-independent tools sometimes 
yield positive results even when vaginal and endocervical cultures are 
negative [9-12]. These new techniques can help to detect a possible 
unusual bacterial infection when vaginal and endocervical cultures are 
negative in cases of chorioamnionitis, preterm birth, or PPROM.
Among multiple antimicrobial combinations proposed for PPROM 
treatment, those based on erythromycin and/or cephalosporins 
have been the most widely used. Novel combinations were recently 
found to be efficacious and were reported to improve perinatal and 
maternal outcomes in comparison to the classic regimen [13,14]. A 
meta-analysis, in 2015, also proposed a prophylactic role for bacterial 
infection in limiting the prolongation of pregnancy in PPROM; however, 
there is insufficient evidence to support the routine use of antibiotics 
during pregnancy to prevent infectious adverse effects, and some 
antibiotherapies may cause additional newborn morbidity [8].
The bacteria identified, here, are habitual colonizing opportunistic 
pathogens. In the present patient, the aim of this study to protect 
mother life and survive her pregnancy [14].
In my case, we give the mother medications according the therapeutic 
protocol as: Antibiotic erythromycin (250 mg orally) as and 
corticosteroids as dexamethasone (4 mg IM) for lung maturation and 
tocolytic medication as MgSo4 (4 g/100 ml Nacl /20 min loading dose) 
these used to stop preterm labor.
I think this protocol give positive results for the mother in my case because:
1. We treat the infection to avoid further complications as abortion
2. We give dexamethasone for lung maturation because of premature 
labor
3. We give (Mgso4) as tocolytic agent to delay premature labor for weeks 
then the mother deliver C/S AT 35 weeks from gestational age.
CONCLUSION
Preventive antibiotic therapy should consider: Opportunistic infections 
by urinary tract infection.
CONSENT FORM
A consent form was applied by hospital archive registration department 
and by senior doctor, nurse, and midwife directors at the same hospital.
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